- $27.02m
- $24.91m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.51 | 11.1 | 19.5 | 30.5 | 29.7 |
Operating Profit | -8.51 | -11.1 | -19.5 | -30.5 | -29.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -8.44 | -13 | -21.8 | -30.3 | -29.3 |
Net Income After Taxes | -8.44 | -13 | -21.8 | -30.3 | -29.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.44 | -13 | -21.8 | -30.3 | -29.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.5 | -21.9 | -24.3 | -30.3 | -29.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.469 | -0.711 | -0.751 | -0.918 | -0.634 |
Dividends per Share |